FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-07 | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-02 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-05 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-27 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-03 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-157 | 73177-157-01 | Furosemide | 10 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-155 | 73177-155-27 | Ketamine Hydrochloride | 5 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 9 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-161 | 73177-161-43 | Methadone Hydrochloride | 10 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-43 | Methadone Hydrochloride | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-28 | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-05 | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-25 | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-04 | Midazolam | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-122 | 73177-122-01 | Atropine Sulfate | .4 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-30 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-16 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-05 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-02 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-25 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-01 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-28 | Morphine Sulfate | 1 mg/1 mL | 2025-1 | valid | 2026-11-02 | |
| STAQ Pharma Inc | 73177-163 | 73177-163-32 | Albuterol | Albuterol | 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-163 | 73177-163-33 | Albuterol | Albuterol | 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-122 | 73177-122-01 | Atropine Sulfate | Atropine Sulfate | .4 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-114 | 73177-114-15 | Desmopressin Acetate | Desmopressin Acetate | 1.5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-123 | 73177-123-02 | Dexmedetomidine Hydrochloride | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-164 | 73177-164-03 | Epinephrine | Epinephrine | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-103 | 73177-103-07 | Fentanyl Citrate | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-103 | 73177-103-05 | Fentanyl Citrate | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-103 | 73177-103-04 | Fentanyl Citrate | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-103 | 73177-103-16 | Fentanyl Citrate | Fentanyl Citrate | 50 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-102 | 73177-102-03 | Fentanyl Citrate | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-102 | 73177-102-01 | Fentanyl Citrate | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-102 | 73177-102-25 | Fentanyl Citrate | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-102 | 73177-102-27 | Fentanyl Citrate | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-102 | 73177-102-05 | Fentanyl Citrate | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-102 | 73177-102-02 | Fentanyl Citrate | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-157 | 73177-157-01 | Furosemide | Furosemide | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-1 | valid | 2026-09-18 |